| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 16 |
| 1 | QUETIAPINE | 11 |
| 2 | ARIPIPRAZOLE | 10 |
| 3 | ESCITALOPRAM | 9 |
| 4 | ESCITALOPRAM OXALATE | 9 |
| 5 | ESCITSLOPRAM | 9 |
| 6 | OLANZAPINE PAMOATE | 9 |
| 7 | ENZALUTAMIDE | 7 |
| 8 | CLOZAPINE | 5 |
| 9 | DENOSUMAB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIPRASIDONE HCL | 3 | 0.0011 |
| 1 | TERBUTALINE SULFATE | 1 | 0.0005 |
| 2 | FINASTERIDE | 16 | 0.0003 |
| 3 | OLANZAPINE PAMOATE | 9 | 0.0002 |
| 4 | RAMUCIRUMAB | 1 | 0.0002 |
| 5 | BICALUTAMIDE | 2 | 0.0001 |
| 6 | CEFTAZIDIME | 1 | 0.0001 |
| 7 | ENZALUTAMIDE | 7 | 0.0001 |
| 8 | ARIPIPRAZOLE | 10 | 0.0001 |
| 9 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 1 | 5-alpha Reductase Inhibitor [EPC] | 16 | 0.0002 |
| 2 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 3 | Androgen Receptor Inhibitor [EPC] | 8 | 0.0001 |
| 4 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 5 | Androgen [EPC] | 1 | 0.0000 |
| 6 | Atypical Antipsychotic [EPC] | 11 | 0.0000 |
| 7 | RANK Ligand Inhibitor [EPC] | 4 | 0.0000 |
| 8 | Aromatase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |